Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-16

FDA Approved: OLANZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Teva Pharmaceuticals' olanzapine product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)